LLLT comes to dentistry
There is a large body of published clinical evidence for the effects of Low Level Laser Therapy (LLLT) on musculoskeletal pain.
Systematic reviews published by the Lancet, BMJ, International Association for the Study of Pain show that LLLT improves the speed and quality of tissue repair, reduces inflammation and has an analgesic action.
Now the European Society for Medical Oncology suggests using LLLT to reduce the incidence of oral mucositis and its associated pain, in patients receiving high-dose chemotherapy or chemoradiotherapy.
There is growing evidence that LLLT works well on a range of oral pathologies and is beneficial for orthodontic procedures and orofacial pain syndromes.
These include improvements in
- Tooth movement
- Osseointegration of implants
- Post extraction pain
- TMJ Dysfunction
- Dentine Hypersensitivity
- Herpes simplex
- Bone density
- Trigeminal Neuralgia
- Aphthous ulcers
- Periodontal disease
- Bells Palsy
LLLT can also reduce the use of anaesthesia for children or be used to reduce the local discomfort of injections.
THOR is a dedicated LLLT manufacturer and training company. We have a CE mark for osteoarthritis, tendinopathies, neck pain and oral mucositis. We also have FDA clearance for temporary relief of muscle and joint pain.
We make it simple
- Online treatment library:
Shows you which probe, what settings and where to treat.
- Online tech and treatment support:
If you cant find a treatment protocol you need, we will write it for you.
- Hands on training:
We run 24 training courses in the USA, 24 in the UK and 6 in Australia every year and is approved for Continuing Education Credits in the USA.
THOR Photobiomodulation Newsletter (See previous edition)
Please add me to the monthly THOR training, research and conference Newsletter.
Product information and purchase enquiry
Sorry for the long form.
We are a global company and our computer needs to know who to direct your enquiry to.
* Mandatory field - this automatically directs your enquiry to the correct department
OUR CUSTOMERS INCLUDE:
The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)